PAHC
Phibro Animal Health·NASDAQ
--
--(--)
--
--(--)
3.85 / 10
Netural
Analyst sentiment is negative with no positive ratings, indicating a lack of bullish conviction. Conversely, money flow analysis registers a strong 7.71/10, showing robust fund inflow characteristics, though specific trends (block, small, medium, large, extra-large) are negative. This divergence between bearish analyst views and positive liquidity underscores the importance of integrating multiple data sources. Investors should consider the strong cash inflow as a potential contrarian signal while remaining cautious of the negative analyst outlook.
Fund Flow Rating
Analyst RatingBuy
Wall Street Opinions
Buy
Strong Buy
0%
Buy
100%
Hold
0%
Sell
0%
Strong Sell
0%
Date2025-11-07
InstitutionJP Morgan
Times predicted2
Historical Win Rate0.0%
What is the analyst consensus for PAHC?
- PAHC holds a Bearish analyst rating, with 100% of experts assigning a Buy grade. Factoring in net Outflows from order flow data, the comprehensive Sentiment Score stands at 3.85/10 (Netural).
